Nutrien slides as antitrust overhang and softer potash-price expectations weigh on sentiment

Nutrien Ltd. (NTR) is down 5.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to renewed investor concern about legal and regulatory scrutiny around fertilizer pricing, alongside a more cautious outlook for potash pricing that could pressure earnings expectations. With the stock having rallied into 2026, negative headlines and bearish analyst framing can have an outsized effect on a down day.

Details:

A U.S. Department of Justice probe into potential fertilizer price-fixing has been reported to involve several large industry participants, adding uncertainty around future pricing power and potential legal costs.

A recently publicized antitrust class action alleges coordination to inflate NPK fertilizer prices over multiple years, which can further weigh on sentiment even before any liability is established.

An analyst downgrade highlighted concerns that potash pricing could weaken starting in Q2 2026, contrasting with expectations for year-over-year price improvement and raising the risk of estimate resets.

Separately, Nutrien’s own outlook materials emphasize that fertilizer markets remain cyclical; when investors become more cautious on commodity pricing, fertilizer producers often trade down together.

Sources:

Investing.com, ClassAction.org, Sahm Capital

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$NTR Hedge Fund Activity

We have seen 294 institutional investors add shares of $NTR stock to their portfolio, and 275 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP added 13,313,817 shares (+440.2%) to their portfolio in Q4 2025, for an estimated $821,728,785
ROYAL BANK OF CANADA removed 3,761,503 shares (-10.8%) from their portfolio in Q4 2025, for an estimated $232,159,965
FMR LLC removed 3,719,002 shares (-23.8%) from their portfolio in Q4 2025, for an estimated $229,536,803
SILCHESTER INTERNATIONAL INVESTORS LLP removed 2,746,328 shares (-67.7%) from their portfolio in Q1 2026, for an estimated $206,935,814
CITADEL ADVISORS LLC removed 2,582,687 shares (-93.8%) from their portfolio in Q4 2025, for an estimated $159,403,441
TORONTO DOMINION BANK added 2,140,598 shares (+72.0%) to their portfolio in Q4 2025, for an estimated $132,117,708
TD ASSET MANAGEMENT INC added 1,559,673 shares (+21.2%) to their portfolio in Q4 2025, for an estimated $96,263,017

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$NTR Analyst Ratings

Wall Street analysts have issued reports on $NTR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Morgan Stanley issued a "Overweight" rating on 01/14/2026

To track analyst ratings and price targets for $NTR, check out Quiver Quantitative's $NTR forecast page.

$NTR Price Targets

Multiple analysts have issued price targets for $NTR recently. We have seen 17 analysts offer price targets for $NTR in the last 6 months, with a median target of $78.0.

Here are some recent targets:

Vincent Sinisi from Morgan Stanley set a target price of $93.0 on 04/08/2026
Lucas Beaumont from UBS set a target price of $67.0 on 03/26/2026
Joel Jackson from BMO Capital set a target price of $90.0 on 03/18/2026
Matthew DeYoe from B of A Securities set a target price of $81.0 on 03/18/2026
Hamir Patel from CIBC set a target price of $90.0 on 03/17/2026
Michael Sison from Wells Fargo set a target price of $100.0 on 03/13/2026
Laurence Alexander from Jefferies set a target price of $96.0 on 03/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.